Table 5. Taeniasis frequency and prevalence by study arm after 24 months of Taenia solium intervention, Peru.
| Study arm | No. taeniasis cases | No. stool samples tested | Prevalence, % |
|
|---|---|---|---|---|
| Crude | Adjusted* (95% CI) | |||
| Ring screening | ||||
| Pig treatment | 3 | 1,155 | 0.26 | 0.32 (0.07–1.45) |
| No pig treatment |
14 |
1,194 |
1.17 |
0.89 (0.22–3.56) |
| Ring treatment | ||||
| Pig treatment | 14 | 1,107 | 1.26 | 0.55 (0.09–3.23) |
| No pig treatment |
15 |
1,099 |
1.36 |
1.54 (0.37–6.51) |
| Mass treatment | ||||
| Pig treatment | 4 | 992 | 0.40 | 0.69 (0.16–2.86) |
| No pig treatment | 4 | 985 | 0.41 | 0.46 (0.09–2.33) |
*Adjusted for number of pigs in the village, baseline village seroprevalence, participant age, and the clustered study design.